Lv4
536 积分 2023-11-07 加入
Treatment-related adverse events of CD3-based T cell-engaging bispecific antibodies in patients with cancer: a meta-analysis of clinical trials
20天前
已完结
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
25天前
已完结
Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer
1个月前
已完结
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic Potential
1个月前
已完结
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
1个月前
已完结
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
1个月前
已完结
Comprehensive analysis of FGFR2b and its correlation with essential biomarkers, intratumoral heterogeneity, and survival in advanced gastric cancer
2个月前
已完结
Molecular Design and Preclinical Evaluation of GenSci143, a Novel B7-H3- and PSMA-Directed Bispecific Antibody-Drug Conjugate, for the Treatment of Prostate Cancer
2个月前
已完结
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer
2个月前
已完结
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
2个月前
已完结
皖公网安备34019202002308
